Sanomedics Inc. (OTC: SIMH) Subsidiary Thermomedics' Caregiver® Thermometer with TouchFree™ Technology Inks 3-YR pact with HealthTrust Purchasing Group, LP via Kentec Medical, Inc.

The revolutionary new device continues to gain major traction in the Clinical Marketplace with agreement to supply HealthTrust Purchasing Group, LP (HPG), which provides services to over 1400 US hospitals and other healthcare facilities.

May 14, 2015, 08:57 ET from Sanomedics, Inc.

SAN DIEGO, May 14, 2015 /PRNewswire/ -- Sanomedics, Inc. (OTC: SIMH); Sanomedics, an international medical technology company focused on developing, manufacturing, and acquiring cutting-edge technology, products and services, announced today that their Thermomedics subsidiary recently strengthened its penetration of the Professional Healthcare vital signs business with the signing of a long-term agreement with HealthTrust Purchasing Group, LP, a world-renowned provider of healthcare supply chain expertise and contracting.

The 3-year agreement goes into effect July 1, 2015. The contract, via distribution partner, Kentec Medical, Inc. of Irvine, California, aligns Thermomedics' Caregiver® TouchFree™ Clinical Thermometer with the highest member-compliance GPO in the nation.

Based in Brentwood, Tennessee, HPG serves an extremely broad and compliant membership whose Clinical Advisory Boards (comprised of expert clinicians) govern and approve all contract awards to allow for the highest compliance at the best price.

Keith Houlihan, the Company's President, commented,  "This arrangement helps to confirm the growing demand for the Caregiver Thermometer's unique combination of accuracy, ease-of-use, reduced cross-contamination, speed, and cost-savings for HPG's broad base of hospitals, medical office,  and all aspects of the continuum of care. Given its competitive pricing model and the fact that no costly probe covers are required for it to deliver results, we're confident that Caregiver is the superior choice among thermometers in the market today and look forward to seeing increased interest in and adoption of it through this strategic partnership."

"The Caregiver's ability to perform in the high patient-volume environment of today's healthcare venues is enhanced by the availability of the items that hospitals have demanded: convenient mounting systems, security protection, in-house biomedical calibration support, and attractive service/warranty programs," noted Ron Benincasa, Executive VP of Marketing and Sales.  "This 3-year contract  will ensure that HPG will be at the forefront of innovative thermometry." Distribution will be handled by the Ameritus division of Kentec Medical, Thermomedics' supply partner.

Designed and developed by the team that first invented Infrared Tympanic Thermometry, led by Thermomedics' Chief Technical Officer, Gary O'Hara, the Caregiver is becoming a primary choice of hospitals and clinics across the nation.

About Sanomedics, Inc.  

Sanomedics, Inc. (OTC: SIMH) is an international medical technology company focused on developing, manufacturing, and acquiring cutting-edge technology, products and services. The Company operates mainly through its subsidiary, Thermomedics, which is dedicated to engineering, marketing and selling the Caregiver TouchFree™ Infrared thermometer. The Caregiver non-contact thermometer is FDA-cleared in the United States for clinical use by medical professionals. The Caregiver provides an accurate and expedited temperature reading without direct contact between patient and medical professional. Sanomedics has established an extensive distribution network with several leading healthcare supply chain providers to increase adoption of the Caregiver device within the medical community worldwide.

Sign up for Sanomedics email news alert system today at:

Follow us on Twitter @Sanomedics

Forward Looking Statements

This press release may contain statements which constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties (for example, the risk that the acquisition is not consummated), and that actual results may differ materially from those in the forward-looking statements as a result of various factors. The Company's periodic filings with the Securities and Exchange Commission should be viewed for a complete understanding of risk and uncertainty.

Investor Contacts:
Phil Carlson / Elizabeth Barker
KCSA Strategic Communications
212-896-1233 / 212-896-1203 /

Media Contacts:
Chloe Font / Andrew Herweg
KCSA Strategic Communications
212-896-1287 / 212-896-1273 /

SOURCE Sanomedics, Inc.